Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Conditions
- DystoniaParkinson DiseaseEssential Tremor
- Registration Number
- NCT03664609
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
- Detailed Description
The purpose of this study is to characterize
1. real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5000
- Must be previously treated with or eligible for implantation with a deep brain stimulation system
- No Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline 5 yrs. post implant Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (19)
St. Joseph's Hospital & Medical Center
🇺🇸Phoenix, Arizona, United States
University of California, San Francisco
🇺🇸San Francisco, California, United States
University of Miami Hospital
🇺🇸Miami, Florida, United States
University of South Florida
🇺🇸Tampa, Florida, United States
St. Luke's Regional Medical Center
🇺🇸Boise, Idaho, United States
Albany Medical Center
🇺🇸Albany, New York, United States
Wake Forest University School of Medicine
🇺🇸Winston-Salem, North Carolina, United States
Allegheny General Hospital
🇺🇸Pittsburgh, Pennsylvania, United States
Swedish Neuroscience Institute
🇺🇸Seattle, Washington, United States
AZ St. Lucas
🇧🇪Gent, Belgium
Scroll for more (9 remaining)St. Joseph's Hospital & Medical Center🇺🇸Phoenix, Arizona, United StatesBoston Scientific Clinical Research ManagerContact855-213-9890BSNClinicalTrials@bsci.com